spacer
spacer

PDBsum entry 4ps3

Go to PDB code: 
protein ligands links
Transferase/transferase inhibitor PDB id
4ps3

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chain
843 a.a.
Ligands
2WH
Waters ×6
PDB id:
4ps3
Name: Transferase/transferase inhibitor
Title: Structure of pi3k gamma in complex with 1-[6-(5-methoxypyridin-3-yl)- 1,3-benzothiazol-2-yl]-3-[2-(1-propyl-1h-imidazol-4-yl)ethyl]urea
Structure: Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform. Chain: a. Fragment: catalytic domain (unp residues 144-1102). Synonym: pi3-kinase subunit gamma, pi3k-gamma, pi3kgamma, ptdins-3- kinase subunit gamma, phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kda catalytic subunit gamma, ptdins-3-kinase subunit p110-gamma, p110gamma, phosphoinositide-3-kinase catalytic gamma polypeptide, serine/threonine protein kinase pik3cg, p120-pi3k.
Source: Homo sapiens. Human. Organism_taxid: 9606. Gene: pi3k gamma, pik3cg. Expressed in: spodoptera frugiperda. Expression_system_taxid: 7108. Expression_system_cell_line: sf21.
Resolution:
2.90Å     R-factor:   0.214     R-free:   0.259
Authors: J.P.Griffith
Key ref: P.N.Collier et al. (2015). Structural basis for isoform selectivity in a class of benzothiazole inhibitors of phosphoinositide 3-kinase γ. J Med Chem, 58, 517-521. PubMed id: 24754609 DOI: 10.1021/jm500362j
Date:
06-Mar-14     Release date:   14-May-14    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
Pfam   ArchSchema ?
P48736  (PK3CG_HUMAN) -  Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform from Homo sapiens
Seq:
Struc:
 
Seq:
Struc:
 
Seq:
Struc:
1102 a.a.
843 a.a.*
Key:    PfamA domain  Secondary structure  CATH domain
* PDB and UniProt seqs differ at 1 residue position (black cross)

 Enzyme reactions 
   Enzyme class 2: E.C.2.7.11.1  - non-specific serine/threonine protein kinase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction:
1. L-seryl-[protein] + ATP = O-phospho-L-seryl-[protein] + ADP + H+
2. L-threonyl-[protein] + ATP = O-phospho-L-threonyl-[protein] + ADP + H+
L-seryl-[protein]
+ ATP
= O-phospho-L-seryl-[protein]
+ ADP
+ H(+)
L-threonyl-[protein]
+ ATP
= O-phospho-L-threonyl-[protein]
+ ADP
+ H(+)
   Enzyme class 3: E.C.2.7.1.137  - phosphatidylinositol 3-kinase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]

      Pathway:
      Reaction: a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol) + ATP = a 1,2-diacyl- sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate) + ADP + H+
1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol)
+ ATP
= 1,2-diacyl- sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate)
+ ADP
+ H(+)
   Enzyme class 4: E.C.2.7.1.153  - phosphatidylinositol-4,5-bisphosphate 3-kinase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]

      Pathway:
      Reaction: a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-4,5-bisphosphate) + ATP = a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3,4,5- trisphosphate) + ADP + H+
1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-4,5-bisphosphate)
+ ATP
= 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3,4,5- trisphosphate)
+ ADP
+ H(+)
   Enzyme class 5: E.C.2.7.1.154  - phosphatidylinositol-4-phosphate 3-kinase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]

      Pathway:
      Reaction: a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol 4-phosphate) + ATP = a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3,4-bisphosphate) + ADP + H+
1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol 4-phosphate)
+ ATP
= 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3,4-bisphosphate)
+ ADP
+ H(+)
Note, where more than one E.C. class is given (as above), each may correspond to a different protein domain or, in the case of polyprotein precursors, to a different mature protein.
Molecule diagrams generated from .mol files obtained from the KEGG ftp site

 

 
    reference    
 
 
DOI no: 10.1021/jm500362j J Med Chem 58:517-521 (2015)
PubMed id: 24754609  
 
 
Structural basis for isoform selectivity in a class of benzothiazole inhibitors of phosphoinositide 3-kinase γ.
P.N.Collier, G.Martinez-Botella, M.Cornebise, K.M.Cottrell, J.D.Doran, J.P.Griffith, S.Mahajan, F.Maltais, C.S.Moody, E.P.Huck, T.Wang, A.M.Aronov.
 
  ABSTRACT  
 
Phosphoinositide 3-kinase γ (PI3Kγ) is an attractive target to potentially treat a range of disease states. Herein, we describe the evolution of a reported phenylthiazole pan-PI3K inhibitor into a family of potent and selective benzothiazole inhibitors. Using X-ray crystallography, we discovered that compound 22 occupies a previously unreported hydrophobic binding cleft adjacent to the ATP binding site of PI3Kγ, and achieves its selectivity by exploiting natural sequence differences among PI3K isoforms in this region.
 

 

spacer

spacer